Skip to Content MayoACCESS MayoLINK...
Improving outcomes through comprehensive controlled substance monitoring - Insights
Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new...
Yuma Regional Medical Center: Strategic expansion to serve a growing community - Insights
Faced with a population increase and the need to expand both laboratory testing capacity and capabilities, Yuma Regional Medical Center leaned into its relationship with Mayo Clinic Laboratories to gain insights to strengthen community...
Mayo Clinic Labs @Work: Sherri Hawkins - Insights
With nearly 30 years at Mayo Clinic, Sherri Hawkins has served in a wide range of laboratory-related roles. Beginning as a laboratorian on the bench and now serving as Group Purchasing Organization (GPO) manager, Sherri has been able to...
MCL @Work: Joune Twist - Insights
Joune Twist has always embraced her natural interest for learning new information and improving processes. In 2019, her curiosity and previous work led her to join Mayo Clinic’s Neuroimmunology Lab. As a medical laboratory scientist, Joune...
Five Ways to Proactively Prepare for Laboratory's Unforeseen Situations - Insights
Unexpected events in the laboratory are an inevitability of the profession. The difference in whether it is manageable or chaotic comes down to the steps taken beforehand. By proactively preparing, you can drastically reduce the number of...
The seven S's of connectivity impact - Insights
With many organizations using a digital-first approach, it is easy to assume that is always the best option. But is it? And what about for your laboratory outreach program? Laboratories should consider these seven S’s when deciding whether...
Urinary ammonium testing - Insights
John Lieske, M.D., discusses Mayo Clinic Laboratories' urinary ammonium testing. A test that takes the guesswork out of determining acid base disorders by giving nephrologists a true understanding of a patient’s true urinary ammonium level.
A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights
Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...
tpmt-testing-treatment-inflammatory-bowel-disease-algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 11/2024 YES TO ANY YES Pretransplant specimen required TPMT activity: Hyperactive TPMT genotype: Any result NUDT15 genotype: Any result TPMT activity:...